Fred Alger Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.3M Buy
1,081,421
+156,235
+17% +$4.62M 0.13% 80
2026
Q1
$25.6M Buy
925,186
+813,314
+727% +$20.9M 0.11% 92
2025
Q4
$2.43M Buy
+111,872
New +$2.21M 0.01% 299

Other funds holding ROIV

Fred Alger Management's ROIV Position: Q2 2026 in Review

Fred Alger Management increased its Roivant Sciences (ROIV) stake by 17% in Q2 2026, buying an estimated $4.62M and bringing the position to 1,081,421 shares worth $38.3M. The position accounts for 0.13% of the portfolio, ranked #80.

Fred Alger Management first reported a position in ROIV in Q4 2025 and has held it in 3 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Fred Alger Management held 1,081,421 shares of Roivant Sciences worth $38.3M as of Q2 2026.
  • Fred Alger Management bought 156,235 Roivant Sciences shares in Q2 2026, an estimated $4.62M.
  • Roivant Sciences made up 0.13% of Fred Alger Management's portfolio in Q2 2026, its #80 holding.
  • Fred Alger Management first reported a position in Roivant Sciences in Q4 2025 and has held it in 3 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.